PMINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Picard Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$15.45+2.70 (+21.18%)
Close on Oct 19, 2026
- Market cap
- $28.67M
- P/E (TTM)
- –
- Dividend yield
- –
Picard Medical statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Picard Medical | Industry median |
|---|---|---|
| Market Cap | $36.13M | $229.23M |
| Enterprise Value | $36.09M | $194.73M |
| PS Ratio | 5.74 | 3.14 |
| PB Ratio | 21.06 | 3.19 |
| P/TBV Ratio | 56.81 | 4.69 |
Enterprise value
| Measure | Picard Medical | Industry median |
|---|---|---|
| EV / Sales | 5.73 | 2.93 |
Income (trailing twelve months)
| Measure | Picard Medical | Industry median |
|---|---|---|
| Revenue | $6.30M | $102.39M |
| Gross Profit | $1.17M | $60.36M |
| Operating Income | -$15.63M | -$4.31M |
| Pretax Income | -$27.98M | -$2.26M |
| Net Income | -$27.99M | -$6.57M |
| EBITDA | -$15.46M | -$1.98M |
Margins
| Measure | Picard Medical | Industry median |
|---|---|---|
| Gross Margin | 18.6% | 55.1% |
| Operating Margin | -248.1% | -6.04% |
| Pretax Margin | -444.2% | -4.11% |
| Profit Margin | -444.3% | -10.5% |
| EBITDA Margin | -245.4% | -2.67% |
Returns
| Measure | Picard Medical | Industry median |
|---|---|---|
| Return on Assets (ROA) | -268.3% | -13.3% |
| Return on Capital Employed (ROCE) | -910.8% | -9.07% |
Growth
| Measure | Picard Medical | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 41.0% | 8.85% |
Balance sheet
| Measure | Picard Medical | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $38.00K | $37.33M |
| Net Cash (Debt) | $38.00K | $3.92M |
| Net Cash Per Share | $0.02 | $0.28 |
| Equity (Book Value) | $1.72M | $57.36M |
| Book Value Per Share | $0.73 | $2.81 |
| Tangible Book Value | $636.00K | $10.71M |
| Working Capital | $141.00K | $54.64M |
Financial position
| Measure | Picard Medical | Industry median |
|---|---|---|
| Current Ratio | 1.02 | 2.50 |
| Quick Ratio | 0.01 | 1.54 |
Cash flow (trailing twelve months)
| Measure | Picard Medical | Industry median |
|---|---|---|
| Operating Cash Flow | -$16.04M | -$653.46K |
Efficiency
| Measure | Picard Medical | Industry median |
|---|---|---|
| Asset Turnover | 0.60 | 0.59 |
| Inventory Turnover | 0.79 | 2.21 |
| Revenue Per Employee | $84.00K | $322.75K |
| Profits Per Employee | -$373.24K | -$52.11K |
| Employee Count | 75 | 197 |
Dividends and yields
| Measure | Picard Medical | Industry median |
|---|---|---|
| Earnings Yield | -77.5% | -6.92% |
| Buyback Yield | -38.0% | 0.78% |
| Shareholder Yield | -38.0% | 0.84% |
Shares
| Measure | Picard Medical | Industry median |
|---|---|---|
| Shares Outstanding | 2,338,630 | 44,856,700 |
| Shares Change (QoQ) | -97.3% | 0.27% |
Taxes
| Measure | Picard Medical | Industry median |
|---|---|---|
| Income Tax | $11.00K | $1.52M |
Scores
| Measure | Picard Medical | Industry median |
|---|---|---|
| Altman Z-Score | -15.77 | 1.95 |
| Piotroski F-Score | 5 | 5 |
Calculated by StockData from Picard Medical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.